Society Discusses Collaboration with NICHD Leadership

On May 6, Endocrine Society members Richard Legro, MD, and Carole Mendelson, PhD, represented the Society at a meeting with leadership from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), including the Acting Director of the NICHD, Catherine Spong, MD.

During the meeting, Legro and Mendelson discussed how to maintain support for the next generation of researchers given the challenging fiscal climate. Spong discussed the results of a review by the Institute of their training programs for graduate students and early career investigators. Moving forward the NICHD will have a greater focus on individual awards to trainees, and will make a concerted effort to increase support for the successful K99/R00 program.

Carole Mendelson, PhD, and Richard Legro, MD, meet with NICHD Acting Director Cathy Spong, MD. NICHD is the second largest source of NIH institute funding for Endocrine Society members.
Carole Mendelson, PhD, and Richard Legro, MD, meet with NICHD Acting Director Cathy Spong, MD. NICHD is the second largest source of NIH institute funding for Endocrine Society members.

The group also discussed challenges facing the biomedical research enterprise generally, including difficulties in maintaining support for investigator-initiated research projects. NICHD described how they are reviewing their grant portfolio and comparing it to other Institutes to determine what variances exist and how they should be managed. Legro and Mendelson shared Society concerns about set-asides for special projects and how these might impact support for the pool of R01-supported investigators.

Spong highlighted the many synergies that exist between the priority areas supported by NICHD and the disease and research interests of Endocrine Society members. She encouraged us to continue to raise the profile of research on women and children’s health and work with the Institute to raise awareness among trainees of the programs at NIH to support their research.

We will continue to work with NICHD to advance endocrine research and explore further opportunities to collaborate. For more information on NICHD priorities and news from the Institute, please see the NICHD website.

You may also like

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

  • Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain  

    On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…

Find more in